Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of temsirolimus, carboplatin,
and paclitaxel in treating patients with advanced solid tumors. Temsirolimus may stop the
growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in
chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth
of tumor cells, either by killing the cells or by stopping them from dividing. Giving
temsirolimus together with chemotherapy may kill more tumor cells.